|
| |
Ambry GeneticsAmbry Genetics provides answers to clinicians, patients, and researchers with comprehensive, reliable, and state-of-the-art DNA diagnostic testing. The Company is well known for its Cystic Fibrosis tests, CF AMPLIFIED™ and 508 FIRST™, which detect more than 99% of the 1500-plus known CF mutations in patients of all ethnicities. With over 15,000 full analyses of the CFTR gene completed, Ambry Genetics has the largest single-laboratory database from which to draw the most experienced diagnostic conclusions. We are proud to be involved with the CF Community through our genetic testing services and relationships with support organizations.
Diabetes genetic testing at Ambry Genetics is thorough and easy with the availability of individual gene sequence analyses and cost-saving reflex pathways for diagnosis of neonatal diabetes, congenital hyperinsulinism, and MODY (Maturity-Onset Diabetes of the Young) Types 1-5.
Ambry Genetics features a unique menu of pulmonary disease genetic tests including The Ambry Test: IPF Telomerase, which is the first clinical test available to define the genetics of idiopathic pulmonary fibrosis. Mutations in Surfactant Proteins B and C, and the ABCA3 protein, cause severe neonatal respiratory distress and/or interstitial lung diseases. We also provide mutation testing for primary ciliary dyskinesia, sequencing for alpha-1-antitrypsin deficiency and pulmonary arterial hypertension, plus research testing of the ADRB2 asthma gene and Surfactant Proteins A and D.
Ambry Genetics created the first comprehensive genetic test for three principle genes (PRSS1, SPINK1, and CFTR) associated with Chronic Pancreatitis and Hereditary Pancreatitis. One in four patients has at least one significant mutation. The Ambry Test: Pancreatitis facilitates identification of genetic contributions to this disease, leading to better patient management.
Clients of Ambry Genetics benefit from expanded customer services including pre-test verification of patient insurance benefits and results discussion with on-staff genetic counselors. Our flexible Research & Development department is structured for rapid development of new tests and quick response to researchers' needs for testing in clinical studies. Ambry Genetics is committed to quality, service, patient care, and promotion of genetic research.
| Contact Details: |
| 100 Columbia #200 |
| Aliso Viejo |
| CA |
| 92656 |
| United States of America |
| Tel: | 949-900-5500 |
| Fax: | 949-900-5501 |
| Email: | |
| WWW: | www.ambrygen.com/
|
|
Loading...
|
Recent Publications by Ambry Genetics: |  |
2008 National Society of Genetic Counselors Presidential address: the NSGC should do something about that... and we are.
Up-Converting Phosphor Technology (UPT) is based on lanthanide-containing,... | 29th May, 2009
| Ambry Genetics Corporation, Aliso Viejo, CA,92656, USA.
| J Genet Couns. 2009 Apr;18(2):105-8. Epub 2009 Feb 20.
DOI Direct Link |
Comprehensive genetic analysis of the cystic fibrosis transmembrane conductance regulator from dried blood specimens--implications for newborn screening.
PURPOSE: In the United States, approximately 1/3,700 babies is born with... | 10th November, 2006
| Ambry Genetics, 100 Columbia #200, Aliso Viejo, CA 92656, USA.
| Genet Med. 2006 Sep;8(9):557-62.
DOI Direct Link |
Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
OBJECTIVES: Chronic pancreatitis is a progressive inflammatory disorder... | 26th October, 2006
| Ambry Genetics,
| Pancreas. 2006 Oct;33(3):221-7.
DOI Direct Link |
Press Releases on Ambry Genetics:
|
 |
| Agilent Technologies Appoints Ambry Genetics as First Certified Service Provider for Agilent's Target Enrichment System for Next-Gen Sequencing |
22nd October, 2009 |
Ambry Genetics |
SANTA CLARA and ALISO VIEJO, Calif., Oct. 22 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) and Ambry Genetics today announced that Ambry is the first organization to achieve Certified Service
|
| 'Ambry Genetics Announces Launch of Chromosomal Microarray to Offer Whole Genome Analysis' |
3rd June, 2009 |
Ambry Genetics |
ALISO VIEJO, Calif., June 3 /PRNewswire/ -- Ambry Genetics is pleased to announce the launch of whole-genome Chromosomal Microarray Analysis (CMA), offering the Ambry CMA: 105K Oligo Array, which is
|
| Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine |
5th May, 2009 |
Ambry Genetics Corp. |
ALISO VIEJO, Calif., May 5 /PRNewswire/ -- Ambry Genetics Corp. announces the implementation of Comparative Genomic Hybridization (CGH) using oligonucleotide arrays through a partnership with Baylor
|
| Ambry Genetics Announces Illumina CSPro Certification for GA Sequencing |
28th April, 2009 |
Ambry Genetics |
ALISO VIEJO, Calif., April 28 /PRNewswire/ -- Ambry Genetics announced today that it has successfully completed Illumina CSPro(TM) certification for Genome Analyzer (GA) Sequencing, gaining entry to
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 108 times since April 2007, the link to the organisation's website has been followed 6 times Recent Search Terms used to find this page: ambry test | the ambry test | ambry genetics jobs in aliso viejo | ambry genetics | ambry genetics aliso viejo ca | CFTR screening with illumina | cystic fibrosis ambry test rare mutation | ambry test | . Search for more companies in Aliso Viejo Search for more companies in CA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Ambry Genetics |
